Our technology (StratosomeTM Biologic System) is built on two basic capabilities: the use of genetic engineering to attach high-value proteins to oilbodies (the structures used by seeds to store oil); and extraction of oilbodies from seeds in a cost-effective manner.
We have chosen safflower as our commercial plant variety. Through genetic manipulation (transgenic), or physical manipulation (non-transgenic) of safflower oilbodies, SemBioSys is able to capitalize on the scalability and economic advantages of plants to produce a wide variety of products such as human pharmaceuticals, personal care ingredients, nutritional oils and agricultural biotechnology products.
For the production of high-value proteins, we believe that our plant technology is unique among transgenic systems as it addresses both production and purification challenges. Because of this, SemBioSys' technology creates a cost-effective solution for the production of pharmaceuticals that are required in large quantities due to the number of people affected by the disease and/or high dosage requirements.
Our technology is protected by an extensive intellectual property portfolio. We have 198 patents issued in various jurisdictions and have 112 patents pending. For further information regarding the scientific basis and patent protection of our technology see our Patents and Scientific Publications page.